| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.1 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.1 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |